Premium
National center for health care technology assessment of therapeutic apheresis for rheumatoid arthritis, 1981
Author(s) -
Heyse Stephen P.,
Renault Pierre R.,
Perry Seymour
Publication year - 1982
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.2920010111
Subject(s) - medicine , apheresis , rheumatoid arthritis , notice , food and drug administration , administration (probate law) , intensive care medicine , health care , public health , family medicine , medical emergency , immunology , nursing , platelet , political science , economics , law , economic growth
Abstract The National Center for Health Care Technology coordinated the Public Health Service's assessment of therapeutic apheresis for rheumatoid arthritis in response to the Health Care Financing Administration's request for advice regarding Medicare coverage of this rapidly emerging technology. The information considered included reports available in the medical literature (as of early 1981), advice from the National Institutes of Health and Food and Drug Administration, advice from the appropriate medical societies, as well as information submitted by interested parties in response to a notice published in the Federal Register announcing the assessment. Synthesis of this information provided the basis for concluding that therapeutic apheresis for rheumatoid arthritis was considered experimental with the possible exception of treatment for life‐threatening complications such as vasculitis, cryoglobulinemia, or hyperviscosity syndrome.